AC Immune clears first hurdle for α-synuclein PET tracer

Mar 31, 2022

With early proof of concept that its α-synuclein PET tracer can selectively detect toxic plaques in multisystem atrophy
patients, AC Immune brings the field a step closer to non-invasively diagnosing diseases involving α-synuclein, and
developing disease-modifying therapies.

Link to PDF article